Generex Biotechnology Corporation - Product Pipeline Review - 2014

Date: January 31, 2014
Pages: 45
Price:
US$ 1,500.00 US$ 1,350.00
Offer valid until December 31, 2014!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G63F76C0112EN
Leaflet:

Download PDF Leaflet

Global Market Direct’s pharmaceuticals report, “Generex Biotechnology Corporation - Product Pipeline Review - 2014” provides data on the Generex Biotechnology Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Generex Biotechnology Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Generex Biotechnology Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Generex Biotechnology Corporation - Brief Generex Biotechnology Corporation overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Generex Biotechnology Corporation human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Generex Biotechnology Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Generex Biotechnology Corporation’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Generex Biotechnology Corporation’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Generex Biotechnology Corporation in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Generex Biotechnology Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Generex Biotechnology Corporation.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Generex Biotechnology Corporation and identify potential opportunities in those areas.
Generex Biotechnology Corporation Snapshot
Generex Biotechnology Corporation Overview
Key Information
Key Facts
Generex Biotechnology Corporation - Research and Development Overview
Key Therapeutic Areas
Generex Biotechnology Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Generex Biotechnology Corporation - Pipeline Products Glance
Generex Biotechnology Corporation - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Generex Biotechnology Corporation - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Generex Biotechnology Corporation - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Generex Biotechnology Corporation - Drug Profiles
insulin human
  Product Description
  Mechanism of Action
  R&D Progress
AE-37
  Product Description
  Mechanism of Action
  R&D Progress
metformin hydrochloride
  Product Description
  Mechanism of Action
  R&D Progress
AE-AI Vaccine
  Product Description
  Mechanism of Action
  R&D Progress
AE-H Vaccine
  Product Description
  Mechanism of Action
  R&D Progress
AE-IG Vaccine
  Product Description
  Mechanism of Action
  R&D Progress
AE-M Vaccine
  Product Description
  Mechanism of Action
  R&D Progress
AE-O Vaccine
  Product Description
  Mechanism of Action
  R&D Progress
fentanyl
  Product Description
  Mechanism of Action
  R&D Progress
Low Molecular Weight Heparin
  Product Description
  Mechanism of Action
  R&D Progress
morphine sulfate
  Product Description
  Mechanism of Action
  R&D Progress
Generex Biotechnology Corporation - Pipeline Analysis
Generex Biotechnology Corporation - Pipeline Products by Therapeutic Class
Generex Biotechnology Corporation - Pipeline Products by Target
Generex Biotechnology Corporation - Pipeline Products by Route of Administration
Generex Biotechnology Corporation - Pipeline Products by Molecule Type
Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action
Generex Biotechnology Corporation - Recent Pipeline Updates
Generex Biotechnology Corporation - Company Statement
Generex Biotechnology Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Generex Biotechnology Corporation, Key Information
Generex Biotechnology Corporation, Key Facts
Generex Biotechnology Corporation - Pipeline by Indication, 2014
Generex Biotechnology Corporation - Pipeline by Stage of Development, 2014
Generex Biotechnology Corporation - Monotherapy Products in Pipeline, 2014
Generex Biotechnology Corporation - Phase III, 2014
Generex Biotechnology Corporation - Phase II, 2014
Generex Biotechnology Corporation - Phase I, 2014
Generex Biotechnology Corporation - Preclinical, 2014
Generex Biotechnology Corporation - Pipeline by Therapeutic Class, 2014
Generex Biotechnology Corporation - Pipeline by Target, 2014
Generex Biotechnology Corporation - Pipeline by Route of Administration, 2014
Generex Biotechnology Corporation - Pipeline by Molecule Type, 2014
Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action, 2014
Generex Biotechnology Corporation - Recent Pipeline Updates, 2014
Generex Biotechnology Corporation, Subsidiaries

LIST OF FIGURES

Generex Biotechnology Corporation - Pipeline by Top 10 Indication, 2014
Generex Biotechnology Corporation - Pipeline by Stage of Development, 2014
Generex Biotechnology Corporation - Monotherapy Products in Pipeline, 2014
Generex Biotechnology Corporation - Pipeline by Top 10 Therapeutic Class, 2014
Generex Biotechnology Corporation - Pipeline by Top 10 Target, 2014
Generex Biotechnology Corporation - Pipeline by Top 10 Route of Administration, 2014
Generex Biotechnology Corporation - Pipeline by Top 10 Molecule Type, 2014
Generex Biotechnology Corporation - Pipeline Products by Top 10 Mechanism of Action, 2014

Ask Your Question

Generex Biotechnology Corporation - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: